Zai Lab Limited (HKG:9688)
Hong Kong · Delayed Price · Currency is HKD 18.27
+0.11 (0.61%)
Apr 17, 2026, 2:45 PM HKT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 20.72 billion as of April 16, 2026. Its market cap has decreased by -32.49% in one year.
Market Cap
20.72B
Enterprise Value
17.08B
Revenue
3.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.27
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 20.72B, an increase of 1,424.74%. That is a compound annual growth rate of 37.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 20.52B | 34.39% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 29.99B |
| TransThera Sciences (Nanjing) | 27.75B |
| Genscript Biotech | 27.61B |
| Duality Biotherapeutics | 25.85B |
| Keymed Biosciences | 21.83B |
| Ascletis Pharma | 18.57B |
| Ascentage Pharma Group International | 18.06B |
| Nanjing Leads Biolabs | 17.67B |